Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00599846 |
The objective of the 18-month trial is to evaluate the natural history of geographic atrophy by assessing the rate of progression of the geographic atrophic lesion over time.
Condition |
---|
Age-Related Macular Degeneration Geographic Atrophy |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Estimated Enrollment: | 1000 |
Study Start Date: | December 2007 |
Estimated Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 55 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients showing signs of geographic atrophy secondary to age-related macular degeneration with no CNV lesion.
Inclusion Criteria:
Exclusion Criteria:
Contact: Petra Kozma-Wiebe | petra.kozma@alconlabs.com |
United States, Texas | |
Houston | Recruiting |
Houston, Texas, United States, 77030 |
Study Director: | Patricia Zilliox | Alcon Research |
Responsible Party: | Alcon ( Patricia Zilliox ) |
Study ID Numbers: | C-06-30 |
Study First Received: | January 13, 2008 |
Last Updated: | January 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00599846 |
Health Authority: | United States: Institutional Review Board |
age-related macular degeneration geographic atrophy |
Pathological Conditions, Anatomical Eye Diseases Disease Progression Retinal Degeneration |
Macular Degeneration Atrophy Retinal Diseases Retinal degeneration |